Y-002

注射用重组人胰 高血糖素样肽-1裸质粒

Report date: 2026/05/11 20:01:57

Base Information

Drug NameY-002
Drug Alias NameY-002
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Northland Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Northland Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A